Affiliated Sites
  • Clinicians Network Payer Bioinformatics
Be The Match

Javascript disabled. This site requires JavaScript How to enable JavaScript.

You are using an outdated browser. Please upgrade your browser to improve your experience.

Close

NMDP

Be The Match
  • About Us
  • Services & Support
  • Cart
  • Transplant Indications and Outcomes
    • HLA Today
    • Disease-Specific Indications and Outcomes
      • AML - Adult
      • AML - Pediatric
      • ALL - Adult
      • ALL - Pediatric
      • Myelodysplastic Syndromes (MDS)
      • CML
      • CLL
      • NHL
      • Hodgkin Lymphoma
      • Multiple Myeloma
      • Severe Aplastic Anemia & Marrow Failure
      • Sickle Cell Disease
      • Immune Deficiency Diseases
      • Inherited Metabolic Disorders
      • Thalassemia
      • Other Diseases
      • Myeloproliferative Neoplasms
    • Additional Outcomes
      • Unrelated vs. Sibling Donor Outcomes
      • Older Patient Outcomes
      • Timing Impact on Outcomes
    • Eligibility
    • Referral Timing Guidelines
    • Order Kits
    • HLA Typing for Family Members
  • Transplant Therapy and Donor Matching
    • Cell Sources
    • HLA Typing and Matching
    • Donor or Cord Blood Search Process
      • Likelihood of Finding a Match
      • Preliminary Search Request
    • Jason Carter Clinical Trials Program
  • Post-Transplant Care
    • Early Complications
    • Vaccinations
    • Long-Term Care Guidelines
      • Pediatric Considerations
    • Chronic GVHD
      • Skin
      • Nails
      • Scalp and Body Hair
      • Eyes
      • Mouth
      • Lungs
      • Muscles, Fascia, Joints
      • Hematopoietic & Immune
      • GI Tract
      • Liver
      • Genitalia
      • Other
    • Post-Transplant Guidelines
  • Medical Education & Research
    • Browse News
      • Results of Study on COVID-19 Vaccine Response in Hematopoietic Cell Transplant Patients Published in eClinicalMedicine
    • Browse Research
    • Education Catalog
      • HLA and Search Strategy Resources
      • GVHD Interactive Provider Network Virtual Learning Series
    • Materials Catalog
    • HCT Presentation Slides
    • About Our Research
    • Transplant Enews
  • Resources
    • Patient Resources
    • Financial Resources
    • Obstetrician Resources
    • Technique Videos
    • Umbilical Cord Blood Collection Training for Public Donation
    • Local Provider Partnership Program
  • Patient Resources
  • Financial Resources
  • Obstetrician Resources
  • Technique Videos
  • Umbilical Cord Blood Collection Training for Public Donation
  • Local Provider Partnership Program

Financial Resources


  • Resources
  • Financial Resources
  • Email
  • Print This Page

Related Resources

  • Network Transplant Centers
  • Patient Resources & Support
  • Materials Catalog

Patient Resources

  • Patient Insurance Coverage Guide
  • Patient Financial Assistance

Financial Resources

Covering the costs of transplant requires careful financial planning, and insurance may not cover all the costs. As part of our efforts to reduce barriers to transplant, we offer financial planning tools and grant programs to help patients with the cost of transplant. We also work with insurance companies and government officials to deepen the understanding of the coverage needs for all transplant patients.

Financial Planning

If transplant is a treatment option for your patient, we can help them learn about their insurance coverage and prepare financially for transplant. Patients can learn about transplant costs, get tips on how to work with their insurance company and access financial planning resources and tools.

Financial Assistance

Be The Match offers a patient financial assistance program that can provide financial relief to your patients. Transplant centers within our Network can apply for these funds on their patient's behalf. There are eligibility requirements and a review process in place to determine how to allocate the funds. Learn more about the Patient Financial Assistance Program and how they can help BMT patients overcome financial barriers.

Medicare Coverage for MDS patients undergoing HCT

Medicare patients with MDS can receive claims coverage from Medicare for HCT through a clinical study approved by the Center for Medicare Services (CMS) under the Coverage with Evidence Development (CED). 

Our research program, CIBMTR (Center for International Blood and Marrow Transplant Research) opened a CMS-approved clinical study to prospectively compare outcomes of allogeneic HCT in MDS patients ≥ 65 years of age with outcomes in younger patients. Find out about enrollment information. 

 

  • Email
  • Print This Page

Slides may be downloaded and used without permission for one-time presentation or personal use.  For publication, use in print or web, or repeated presentations, please submit a Copyright Request Form.

Keep In Touch

  • Contact Us
  • Transplant Enews

Our Websites

  • Be The Match
  • Be The Match Mexico
  • Be The Match BioTherapies
  • CIBMTR
  • Jason Carter Clinical Trials Search
National Marrow Donor Program —
Entrusted and under contract to operate the C.W. Bill Young Cell Transplantation Program, including Be The Match Registry®.
Copyright © 1996-2023 National Marrow Donor Program. All Rights Reserved. Terms of Use | Privacy Policy | Trademark & Copyright